Scout Investments Inc. lowered its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 1.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 282,400 shares of the specialty pharmaceutical company’s stock after selling 4,429 shares during the period. Scout Investments Inc. owned approximately […]
Supernus Pharmaceuticals (NASDAQ:SUPN) PT Lowered to $41 00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Get Free Report) SVP Frank Mottola sold 1,110 shares of the business’s stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $28.13, for a total value of $31,224.30. Following the sale, the senior vice president now owns 5,681 shares of […]
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Get Free Report)’s stock price reached a new 52-week low during trading on Wednesday after StockNews.com downgraded the stock from a buy rating to a hold rating. The company traded as low as $23.34 and last traded at $23.46, with a volume of 45380 shares trading hands. The stock had […]
Supernus Pharmaceuticals (NASDAQ:SUPN – Get Rating) had its price target hoisted by equities researchers at Piper Sandler from $45.00 to $46.00 in a note issued to investors on Wednesday, The Fly reports. Piper Sandler’s price objective would indicate a potential upside of 27.14% from the company’s current price. SUPN has been the subject of a […]